Baloxavir and Treatment-Emergent Resistance: Public Health Insights and Next Steps

被引：35

作者：

Gubareva, Larisa V. ^{[1
]}

Fry, Alicia M. ^{[1
]}

机构：

[1] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA

来源：

JOURNAL OF INFECTIOUS DISEASES | 2020年 / 221卷 / 03期

关键词：

INFLUENZA; OSELTAMIVIR;

D O I：

10.1093/infdis/jiz245

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：337 / 339

页数：3

共 16 条

[1]

[Anonymous], GUID US ANT AG AD AD

[2] Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised phase 2 trial [J].

Beigel, John H. ;

Bao, Yajing ;

Beeler, Joy ;

Manosuthi, Weerawat ;

Slandzicki, Alex ;

Dar, Sadia M. ;

Panuto, John ;

Beasley, Richard L. ;

Perez-Patrigeon, Santiago ;

Suwanpimolkul, Gompol ;

Losso, Marcelo H. ;

McClure, Natalie ;

Bozzolo, Dawn R. ;

Myers, Christopher ;

Holley, H. Preston, Jr. ;

Hoopes, Justin ;

Lane, H. Clifford ;

Hughes, Michael D. ;

Davey, Richard T. .

LANCET INFECTIOUS DISEASES, 2017, 17 (12) :1255-1265

[3] The global spread of drug-resistant influenza [J].

Chao, Dennis L. ;

Bloom, Jesse D. ;

Kochin, Beth F. ;

Antia, Rustom ;

Longini, Ira M., Jr. .

JOURNAL OF THE ROYAL SOCIETY INTERFACE, 2012, 9 (69) :648-656

[4] Influenza Vaccine Effectiveness in the United States During the 2016-2017 Season [J].

Flannery, Brendan ;

Chung, Jessie R. ;

Monto, Arnold S. ;

Martin, Emily T. ;

Belongia, Edward A. ;

McLean, Huong Q. ;

Gaglani, Manjusha ;

Murthy, Kempapura ;

Zimmerman, Richard K. ;

Nowalk, Mary Patricia ;

Jackson, Michael L. ;

Jackson, Lisa A. ;

Rolfes, Melissa A. ;

Spencer, Sarah ;

Fry, Alicia M. ;

Petrie, Joshua G. ;

Malosh, Ryan E. ;

McSpadden, E. J. ;

Segaloff, Hannah E. ;

Cheng, Caroline K. ;

Truscon, Rachel ;

Johnson, Emileigh ;

Lamerato, Lois E. ;

Ivacic, Lynn C. ;

King, Jennifer P. ;

Meece, Jennifer K. ;

Palmquist, Madalyn M. ;

Guzinski, Sherri A. ;

Robertson, Anne ;

Kossie, Ashley ;

Smith, Michael ;

Hoelscher, Vanessa ;

Clipper, Lydia ;

Walker, Kimberley ;

Volz, Marcus ;

Rao, Arundhati ;

Fader, Robert ;

Munoz-Maldonado, Yolanda ;

Reis, Michael ;

Williams, John V. ;

Balasubramani, Goundappa K. ;

Reis, Evelyn C. ;

Eng, Heather ;

Ford, Samantha ;

Bear, Todd M. ;

Ricci, Edmund M. ;

Hickey, Robert W. ;

Moehling, Krissy K. ;

Raviotta, Jonathan M. ;

Sax, Theresa M. .

CLINICAL INFECTIOUS DISEASES, 2019, 68 (11) :1798-1806

[5]

Hayden FG, 2019, CURR OPIN INFECT DIS, V32, P176, DOI [10.1097/qco.0000000000000532, 10.1097/QCO.0000000000000532]

[6] Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents [J].

Hayden, Frederick G. ;

Sugaya, Norio ;

Hirotsu, Nobuo ;

Lee, Nelson ;

de Jong, Menno D. ;

Hurt, Aeron C. ;

Ishida, Tadashi ;

Sekino, Hisakuni ;

Yamada, Kota ;

Portsmouth, Simon ;

Kawaguchi, Keiko ;

Shishido, Takao ;

Arai, Masatsugu ;

Tsuchiya, Kenji ;

Uehara, Takeki ;

Watanabe, Akira .

NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (10) :913-923

[7] Triple Combination Antiviral Drug (TCAD) Composed of Amantadine, Oseltamivir, and Ribavirin Impedes the Selection of Drug-Resistant Influenza A Virus [J].

Hoopes, Justin D. ;

Driebe, Elizabeth M. ;

Kelley, Erin ;

Engelthaler, David M. ;

Keim, Paul S. ;

Perelson, Alan S. ;

Rong, Libin ;

Went, Gregory T. ;

Nguyen, Jack T. .

PLOS ONE, 2011, 6 (12)

[8]

Infectious Disease Society of America, HCV GUID REC TEST MA

[9] Identification of the I38T PA Substitution as a Resistance Marker for Next-Generation Influenza Virus Endonuclease Inhibitors [J].

Jones, Jeremy C. ;

Kumar, Gyanendra ;

Barman, Subrata ;

Najera, Isabel ;

White, Stephen W. ;

Webby, Richard J. ;

Govorkova, Elena A. .

MBIO, 2018, 9 (02)

[10]

National Institute of Infectious Diseases, 2019, ANT RES SURV JAP MAR

← 1 2 →